Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8252795 Imidazopyridazinecarbonitriles useful as kinase inhibitors

Patent 8252795 was granted and assigned to Bristol-Myers Squibb on August, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 6 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11999742 Substituted pyrrolo[1,2-b]pyridazines as anthelmintics
0
Edits on 24 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11964977 Anthelmintic heterocyclic compounds
0
Edits on 29 Nov, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 29 Nov, 2023
Edits made to:
Article (+62 characters)
Article

Patent abstract

The invention provides compounds of Formula (I)

Edits on 21 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 21 Sep, 2023
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Andrew James Nation0
Ashvinikumar V. Gavai0
Brian E. Fink0
Libing Chen0
Liqi He0
Litai H. Zhang0
Soong-Hoon Kim0
Yufen Zhao0
Edits on 21 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08252795 Imidazopyridazinecarbonitriles useful as kinase inhibitors US Patent 8252795 Imidazopyridazinecarbonitriles useful as kinase inhibitors

Infobox
Patent Number
08252795
Patent Number
8252795
Edits on 15 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 15 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 08252795 Imidazopyridazinecarbonitriles useful as kinase inhibitors

Infobox
Is a
Patent
Patent
Current assignee
Bristol-Myers Squibb
Bristol-Myers Squibb
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08252795
Date of patent
August 28, 2012
Patent application number
12575589
Date Filed
October 8, 2009
Patent primary examiner
‌
Paul V Ward

Find more entities like US Patent 8252795 Imidazopyridazinecarbonitriles useful as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.